MolecuLight i:X Imaging Device

DEVICE3 trials

Sponsors

MolecuLight Inc.

Conditions

Non Healing Diabetic Foot UlcerWoundWounds

Unknown Phase

Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds

CompletedNCT02682069

MolecuLight Inc.Wounds

Start: 2016-02-29End: 2017-08-30Updated: 2020-02-26

Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds

MolecuLight Inc.Wound

Start: 2018-05-23End: 2020-12-30Updated: 2020-03-06

Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care

CompletedNCT04207099

MolecuLight Inc.Non Healing Diabetic Foot Ulcer

Start: 2020-02-14End: 2024-04-01Updated: 2026-07-07

Related Papers

Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations.

2023-04-1121 citations

Reliance on Clinical Signs and Symptoms Assessment Leads to Misuse of Antimicrobials: <i>Post hoc</i> Analysis of 350 Chronic Wounds

Advances in Wound Care2021-10-2922 citations

Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden

Journal of Wound Care2019-06-0265 citations

Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study.

2017-08-0165 citations